tiprankstipranks
Trending News
More News >
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
US Market

Relmada Therapeutics (RLMD) Technical Analysis

Compare
346 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
4Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Relmada Therapeutics’s (RLMD) Moving Averages Convergence Divergence (MACD) indicator is 0.09, suggesting Relmada Therapeutics is a Sell.
Relmada Therapeutics’s (RLMD) 20-Day exponential moving average is 0.59, while Relmada Therapeutics’s (RLMD) share price is $0.74, making it a Buy.
Relmada Therapeutics’s (RLMD) 50-Day exponential moving average is 0.50, while Relmada Therapeutics’s (RLMD) share price is $0.74, making it a Buy.

Relmada Therapeutics (RLMD) Pivot Points

Jun 05, 2025, 11:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.65
0.67
0.68
0.70
0.71
0.73
0.74
Fibonacci
0.67
0.68
0.69
0.70
0.71
0.72
0.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Relmada Therapeutics (RLMD) Moving Averages

Jun 05, 2025, 11:14 PM
Period
Simple
Exponential
MA5
0.72Buy
0.71Buy
MA10
0.68Buy
0.67Buy
MA20
0.55Buy
0.59Buy
MA50
0.43Buy
0.50Buy
MA100
0.38Buy
0.66Buy
MA200
1.44Sell
1.49Sell
Relmada Therapeutics’s (RLMD) 10-Day exponential moving average is 0.67, while Relmada Therapeutics’s (RLMD) share price is $0.74, making it a Buy.
Relmada Therapeutics’s (RLMD) 100-Day exponential moving average is 0.66, while Relmada Therapeutics’s (RLMD) share price is $0.74, making it a Buy.
Relmada Therapeutics’s (RLMD) stock price is $0.74 and Relmada Therapeutics’s (RLMD) 50-day simple moving average is 0.43, creating a Buy signal.
Relmada Therapeutics’s (RLMD) stock price is $0.74 and Relmada Therapeutics’s (RLMD) 100-day simple moving average is 0.38, creating a Buy signal.
Relmada Therapeutics’s (RLMD) stock price is $0.74 and Relmada Therapeutics’s (RLMD) 200-day simple moving average is 1.44, creating a Sell signal.

Relmada Therapeutics (RLMD) Technical Indicators

Jun 05, 2025, 11:14 PM
Name
Value
Implied Action
RSI (14)
67.47
Neutral
STOCH (9,6)
81.78
Sell
STOCHRSI (14)
87.07
Sell
MACD (12,26)
0.09
Sell
ADX (14)
42.00
Neutral
Williams %R
-7.24
Sell
CCI (14)
89.10
Neutral
ATR (14)
0.08
-
Ultimate Oscillator
66.41
Neutral
ROC
72.09
Buy
Relmada Therapeutics’s (RLMD) Relative Strength Index (RSI) is 67.47, creating a Neutral signal.
Relmada Therapeutics’s (RLMD) Trend Strength Indicator (ADX) is 42.00, creating a Neutral signal.
Relmada Therapeutics’s (RLMD) Commodity Channel Index (CCI) is 89.10, creating a Neutral signal.
Relmada Therapeutics’s (RLMD) Price Rate of Change (ROC) is 72.09, creating a Buy signal.

FAQ

Is RLMD a Buy, Hold, or Sell?
Based on RLMD’s technical indicators, RLMD is a Buy.
    What is RLMD’s RSI (14)?
    RLMD’s RSI (14) is 67.47, which suggests RLMD is a Neutral.
      What is RLMD’s MACD?
      RLMD’s MACD is 0.09, which suggests RLMD is a Sell.
        What is RLMD’s 5-day moving average?
        RLMD’s 5-day moving average is 0.72, which suggests RLMD is a Buy.
          What is RLMD’s 20-day moving average?
          RLMD 20-day moving average is 0.55, which suggests RLMD is a Buy.
            What is RLMD’s 50-day moving average?
            RLMD’s 50-day moving average is 0.43, which suggests RLMD is a Buy.
              What is RLMD’s 200-day moving average?
              RLMD’s 200-day moving average is 1.44, which suggests RLMD is a Sell.
                What is RLMD’s Williams % R (14)?
                RLMD’s Williams % R (14) is -7.24, which suggests RLMD is a Sell.
                  What is RLMD’s CCI (14)?
                  RLMD’s CCI (14) is 89.10, which suggests RLMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis